What is the best treatment for a skin infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Skin Infections

For skin infections, amoxicillin-clavulanate (875/125 mg twice daily for 7 days) is the recommended first-line treatment due to its broad coverage against common causative organisms including Staphylococcus aureus and Streptococcus species. 1, 2

Classification and Treatment Algorithm

1. Uncomplicated Skin Infections

  • Impetigo/Localized infections:
    • First choice: Topical mupirocin 2% ointment applied 2-3 times daily for 5-7 days 2
    • Alternative topical: Retapamulin or fusidic acid 2
    • If oral therapy needed: Cephalexin 500 mg four times daily for 7-10 days 3, 4

2. Moderate Skin and Soft Tissue Infections

  • Cellulitis/Erysipelas:
    • First choice: Amoxicillin-clavulanate 875/125 mg twice daily for 7 days 1, 2
    • For penicillin allergy: Clindamycin 300-450 mg every 6-8 hours for 7-10 days 5
    • MRSA suspected: Trimethoprim-sulfamethoxazole (160-800 mg) twice daily or doxycycline 100 mg twice daily 1, 2

3. Severe/Complicated Skin Infections

  • Necrotizing infections/Severe cellulitis:
    • First choice: Piperacillin-tazobactam plus vancomycin IV 1
    • Alternative: Carbapenem (imipenem, meropenem, ertapenem) 1
    • For mixed infections: Ampicillin-sulbactam 1.5-3g IV every 6-8 hours plus clindamycin 600-900 mg IV every 8 hours 1

4. Animal/Human Bite Infections

  • First choice: Amoxicillin-clavulanate 875/125 mg twice daily 1
  • Alternative: Doxycycline 100 mg twice daily (excellent for Pasteurella multocida) 1

Special Considerations

For Children

  • Adjust dosing by weight:
    • Cephalexin: 25-50 mg/kg/day divided in 4 doses 3
    • For otitis media: 75-100 mg/kg/day in 4 divided doses 3
    • Clindamycin: 8-16 mg/kg/day divided in 3-4 doses for serious infections 5
  • Avoid doxycycline in children under 8 years 2

For Immunocompromised Patients

  • Use broader spectrum coverage initially
  • Consider early IV therapy with piperacillin-tazobactam or a carbapenem 1
  • Obtain cultures before starting antibiotics when possible 2

Duration of Treatment

  • Standard duration: 7-10 days 2, 6
  • For streptococcal infections: minimum 10 days to prevent complications 3, 5
  • For necrotizing infections: continue until clinical improvement, often 2-3 weeks 1

Common Pitfalls to Avoid

  1. Failing to consider MRSA in recalcitrant infections - obtain cultures when infections don't respond to initial therapy 2
  2. Using penicillin alone for mixed infections - it's inferior to broader spectrum options 4
  3. Inadequate duration of therapy - particularly for streptococcal infections which require at least 10 days 5
  4. Relying solely on topical therapy for extensive disease 2, 6
  5. Not addressing underlying conditions that may predispose to recurrent infection 2

When to Consider IV Therapy

  • Extensive or rapidly spreading infection
  • Systemic symptoms (fever, hypotension)
  • Immunocompromised host
  • Failed oral therapy
  • Necrotizing infections 1

Tetanus Prophylaxis

  • Administer tetanus toxoid to patients without vaccination within 10 years 1
  • Tdap is preferred over Td if not previously given 1

By following this treatment algorithm and considering the patient-specific factors, most skin infections can be effectively managed with appropriate antibiotic therapy, resulting in reduced morbidity and improved outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Skin and soft tissue infection.

Indian journal of pediatrics, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.